Some Publication Citations for Capralogics Antibody Services
Alpaca: Chen, Jin Y., et al. “A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia.” Clinical Immunology 253 (2023): 109678. Abstract
Llama: Hollingsworth, Scott A., et al. “Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants.” Scientific Reports 13.1 (2023): 13668. Article
Alpaca: Weinstein, Jules B., et al. “A potent alpaca-derived nanobody that neutralizes SARS-CoV-2 variants.” Iscience 25.3 (2022): 103960. Article
Alpaca: Bates, Timothy A., et al. “Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants.” Science immunology 7.68 (2022): eabn8014. Article
Llama: Mast, Fred D., et al. “Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape.” Elife 10 (2021): e73027. Article
Llama: Xu, Jianliang, et al. “Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.” Nature 595.7866 (2021): 278-282. Article
Llama: Longhin, Elena, et al. “Isolation and characterization of nanobodies against a zinc-transporting p-type atpase.” Antibodies 7.4 (2018): 39. Article
Alpaca, Llama: Thompson, Mary K., et al. “Optimizing selection of large animals for antibody production by screening immune response to standard vaccines.” Journal of immunological methods 430 (2016): 56-60. Article
Llama: Nguyen, Van Son, et al. “Inhibition of type VI secretion by an anti-TssM llama nanobody.” PLoS One 10.3 (2015): e0122187. Article
Llama: Fridy, Peter C., et al. “A robust pipeline for rapid production of versatile nanobody repertoires.” Nature methods 11.12 (2014): 1253-1260. Article
Llama: Desmyter, Aline, et al. “Viral infection modulation and neutralization by camelid nanobodies.” Proceedings of the National Academy of Sciences 110.15 (2013): E1371-E1379. Article
Rabbit: Sarayloo, Faezeh, et al. “SKOR1 has a transcriptional regulatory role on genes involved in pathways related to restless legs syndrome.” European Journal of Human Genetics 28.11 (2020): 1520-1528. Article
Rabbit: Witwicka, Hanna, et al. “TRAFD1 (FLN29) interacts with Plekhm1 and regulates osteoclast acidification and resorption.” Plos one 10.5 (2015): e0127537. Article
Goat: Hu, Charles Chen, et al. “Active immunity induced by passive IgG post-exposure protection against ricin.” Toxins 6.1 (2014): 380-393. Article
Rabbit: Abeijon, Claudia, et al. “Identification and diagnostic utility of Leishmania infantum proteins found in urine samples from patients with visceral leishmaniasis.” Clinical and Vaccine Immunology 19.6 (2012): 935-943. Article
Rabbit: Vasale, Jessica J., et al. “Sequential rounds of RNA-dependent RNA transcription drive endogenous small-RNA biogenesis in the ERGO-1/Argonaute pathway.” Proceedings of the National Academy of Sciences 107.8 (2010): 3582-3587. Article
Sheep: Schmeisser, Falko, et al. “An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.” Vaccine 28.12 (2010): 2442-2449. Abstract
Rabbit: Golitsina, Nina L., et al. “Evaluation of the role of three candidate human kinases in the conversion of the hepatitis C virus inhibitor 2′-C-methyl-cytidine to its 5′-monophosphate metabolite.” Antiviral research 85.3 (2010): 470-481. Abstract
Rabbit: Vasale, Jessica J., et al. “Sequential rounds of RNA-dependent RNA transcription drive endogenous small-RNA biogenesis in the ERGO-1/Argonaute pathway.” Proceedings of the National Academy of Sciences 107.8 (2010): 3582-3587. Article
Rabbit: Li, Yunping, et al. “Stretch activates human myometrium via ERK, caldesmon and focal adhesion signaling.” PloS one 4.10 (2009): e7489. Article
Rabbit: Hernandez JA, Igarashi RY, Soboh B, Curatti L, Dean DR, Ludden PW, Rubio LM. NifX and NifEN exchange NifB cofactor and the VK-cluster, a newly isolated intermediate of the iron-molybdenum cofactor biosynthetic pathway. Mol Microbiol. 2007 Jan 63(1): 177-92 Article
Rabbit: Oh SW, Mukhopadhyay A, Dixit BL, Raha T, Green MR, Tissenbaum HA. Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation. Nat Genet. 2006 Feb;38(2):251-7 Abstract
Sheep: Jerdeva, Galina V., et al. “Dominant-negative PKC-ε impairs apical actin remodeling in parallel with inhibition of carbachol-stimulated secretion in rabbit lacrimal acini.” American Journal of Physiology-Cell Physiology 289.4 (2005): C1052-C1068. Article
Rabbit: Pantua, Homer, et al. “Characterization of an alternate form of Newcastle disease virus fusion protein.” Journal of virology 79.18 (2005): 11660-11670. Article
Rabbit: Malik, Sundeep, et al. “Ric-8 enhances G protein βγ-dependent signaling in response to βγ-binding peptides in intact cells.” Molecular pharmacology 68.1 (2005): 129-136. Article
Rabbit: O’Connor, Susan M., and John D. Coates. “Universal immunoprobe for (per) chlorate-reducing bacteria.” Applied and environmental microbiology 68.6 (2002): 3108-3113. Article
Sheep: Hubert, Rene S., et al. “STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors.” Proceedings of the National Academy of Sciences 96.25 (1999): 14523-14528. Article
Some Patent Application Citations for Capralogics Antibody Services
Llama: Spillner, Edzard, et al. Displacers of Ige-Fceri. WO2024003376A1, 4 Jan. 2024
Llama: Spillner, Edzard, et al. Single Domain Antibodies against Bee Venom Epitopes. WO2023170282A1, 14 Sept. 2023
Llama: Hermiston, Terry, et al. Camelid Antibodies against Activated Protein c and Uses Thereof. WO2023168429A2, 7 Sept. 2023
Llama: Hatefi, Arash, and Shahryar Khoshtinat NIKKHOI. Single-Domain High Affinity Antibodies and Methods of Use Thereof. WO2023129819A2, 6 July 2023
Llama: Shi, Yi, and Yufei Xiang. Broadly Neutralizing Nanobodies for Coronavirus and Uses Thereof. WO2023039577A1, 16 Mar. 2023
Llama: Shi, Yi, et al. Compositions and Methods for Identifying Nanobodies and Nanobody Affinities. EP4143582A1, 8 Mar. 2023
Llama: Balthasar, Joseph P., et al. Compositions and Methods for Reducing Off-Target Toxicity of Antibody Drug Conjugates. WO2021113740A1, 10 June 2021
Llama: MORGENSTERN, Travis, and Henry M. COLECRAFT. Compositions and Methods for Genetically-Encoded High Voltage-Activated Calcium Channel Blockers Using Engineered Ubiquitin Ligases. WO2020198637A1, 1 Oct. 2020
Rabbit: Stojdl, David F. Compositions and Methods for Glioblastoma Treatment. WO2015154197A1, 15 Oct. 2015
Rabbit: Tissenbaum, Heidi, and Seung Oh. Methods of Identifying Longevity Modulators and Therapeutic Methods of Use Thereof. US20060272039A1, 30 Nov. 2006
Rabbit: Mello, Craig. Dicer Interacting Proteins and Uses Therefor. US20060228361A1, 12 Oct. 2006
Our Licenses & Assurances include EC1069/2009 and EC142/2011
Do you need custom antibody development services?
Do you need off-the-shelf polyclonal antibodies?
